Insight Biotechnology search:

<<First <Prev Next> Last>>

Search Results for:
Catalogue No	Partner	Description	Species	Application
HY-P9924-1mg	MedChemexpress LLC	Ixekizumab [CAS 1143503-69-8]		COVID-19-immunoregulation
HY-P9924-5mg	MedChemexpress LLC	Ixekizumab [CAS 1143503-69-8]		COVID-19-immunoregulation
HY-P99278-1mg	MedChemexpress LLC	AdecatuMu mab [CAS 503605-66-1]		Cancer-programmed cell death
HY-P99278-10mg	MedChemexpress LLC	AdecatuMu mab [CAS 503605-66-1]		Cancer-programmed cell death
HY-P99278-5mg	MedChemexpress LLC	AdecatuMu mab [CAS 503605-66-1]		Cancer-programmed cell death
HY-P99390-1mg	MedChemexpress LLC	Tepoditamab [CAS 2044679-53-8]		Cancer-programmed cell death
HY-P99390-5mg	MedChemexpress LLC	Tepoditamab [CAS 2044679-53-8]		Cancer-programmed cell death
HY-P99410-1mg	MedChemexpress LLC	Ordesekimab [CAS 879293-15-9]		COVID-19-immunoregulation
HY-P99410-10mg	MedChemexpress LLC	Ordesekimab [CAS 879293-15-9]		COVID-19-immunoregulation
HY-P99410-5mg	MedChemexpress LLC	Ordesekimab [CAS 879293-15-9]		COVID-19-immunoregulation
HY-P99412-1mg	MedChemexpress LLC	Lusvertikimab [CAS 2375835-91-7]		Cancer-Kinase/protease
HY-P99412-10mg	MedChemexpress LLC	Lusvertikimab [CAS 2375835-91-7]		Cancer-Kinase/protease
HY-P99412-5mg	MedChemexpress LLC	Lusvertikimab [CAS 2375835-91-7]		Cancer-Kinase/protease
HY-P9948-1mg	MedChemexpress LLC	Alemtuzumab [CAS 216503-57-0]		Cancer-programmed cell death
HY-P9948-10mg	MedChemexpress LLC	Alemtuzumab [CAS 216503-57-0]		Cancer-programmed cell death
HY-P9948-25mg	MedChemexpress LLC	Alemtuzumab [CAS 216503-57-0]		Cancer-programmed cell death
HY-P9948-5mg	MedChemexpress LLC	Alemtuzumab [CAS 216503-57-0]		Cancer-programmed cell death
HY-P9948-50mg	MedChemexpress LLC	Alemtuzumab [CAS 216503-57-0]		Cancer-programmed cell death
HY-P99706-1mg	MedChemexpress LLC	Ligufalimab [CAS 2428381-55-7]
HY-P3332A-1mg	MedChemexpress LLC	3x DYKDDDDK Tag (TFA)
HY-P3332A-10mg	MedChemexpress LLC	3x DYKDDDDK Tag (TFA)
HY-P3332A-5mg	MedChemexpress LLC	3x DYKDDDDK Tag (TFA)